This press release contains forward-looking statements including targets, estimates, plans, expectations, goals and projections, which involve risks and uncertainties, including risks associated with our ability to fund, successfully develop and obtain regulatory approvals for retigabine, our ability to commercialize and grow prescriptions of retigabine if approved, our ability to meet financial c